About Cancer Prevention Research
Cancer Prevention Research publishes original studies, reviews, and commentaries in the fields of cancer prevention and interception. The journal comprises preclinical, clinical, translational, and implementation research, with special attention given to molecular discoveries and an emphasis on building translational and mechanistic bridges between the basic, clinical, and population sciences. The editors welcome manuscript submissions that describe mechanisms of carcinogenesis; develop preventive interventions to intercept cancer development at early stages; or evaluate implementation of evidence-based preventive practices. In-scope areas of particular interest follow:
- Biology of susceptibility and premalignancy, including mechanistic studies to understand cancer formation and identify molecular targets for cancer prevention.
- Risk factors, particularly the following: microbiome and viruses; chronic infection; behavioral and psychosocial factors (including diet, alcohol, vaping/tobacco, and inactivity); obesity; inflammation; metabolism; hormones; genetic risk factors; aging; and environmental carcinogens (including radiation and sunlight).
- Multimorbidities of cancer and other chronic diseases, including studies on common pathways that can be targeted both for cancer prevention as well as for overall health improvement.
- Risk assessment and cancer screening, including studies on cancer heredity and utilization of machine-learning/artificial intelligence in predicting risk.
- Early detection, including studies on new technologies and biomarkers such as liquid biopsy, multicancer/multitarget assays applied in early detection settings, and “-omics” analyses of preneoplasia samples to detect cancer early.
- Preclinical studies on preventive interventions and their mechanisms. Preventive interventions of interest include chemoprevention, immunoprevention (including checkpoint inhibitors, immunological approaches to prevention, and vaccination), and nutritional/behavioral prevention. Novel preclinical models (tissue culture and animals) to test preventive strategies are also of interest.
- Clinical studies on preventive interventions. Articles may describe prevention-centric clinical trials at any phase.
- Dissemination and implementation research. Studies should describe how to implement an evidence-based intervention, practice, or policy in a successful, highly impactful way. Relevant implementation-related concerns, such as effectiveness, efficiency, scaling, required personnel, and eligible participants, should be addressed.
- Cancer disparities science that addresses the disproportionate risk that certain groups face. Groups may be affected by disparities on the basis of race, ethnicity, age, gender, sexual orientation/gender identity, socioeconomic status, insurance status, geographic residence, linguistic or cultural isolation, access to care, etc.
- Health policy and global cancer control studies that are focused on the discovery or implementation of evidence-based interventions involving educational programs, infrastructures, and delivery of services addressing clinical or social needs to underserved communities.
Cancer Prevention Research welcomes submission of original research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Instructions for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.
Manuscripts are stringently reviewed for high standards of scientific merit, and only those articles that report results of novel, timely, and broadly significant research are accepted for publication.
Submit your article to Cancer Prevention Research
For detailed metrics about Cancer Prevention Research and the other AACR journals see AACR Journals Metrics.
Editors and Editorial Board
Editorial oversight of Cancer Prevention Research and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board with support from journal staff. See Editorial Board for more information.
Copyright, Permissions and Access
Material published in Cancer Prevention Research is covered and protected by copyright. Authors who wish to publish articles and other material in AACR journals must formally transfer copyright to the AACR but are granted considerable reuse rights. The final typeset version of every published article is rendered freely accessible 12 months after publication. Authors who prefer for their article to be immediately freely accessible online may make this selection by paying an additional fee through the AACR AuthorChoice option. In addition, the AACR assists authors in satisfying major funder Open Access archiving mandates by depositing the accepted author version of their article in a designated public repository. For additional details about all these topics, see Copyright, Permissions and Access
To defray publication costs and to support other AACR programs, publication in Cancer Prevention Research involves the payment of a fixed publication fee and an additional fee for any color figures. If no financial support exists, authors may apply for a waiver of the fixed publication fee at the time of submission. See Publication Fees for further details.
Cancer Prevention Research (CAPR) (Print ISSN: 1940-6207; Online ISSN: 1940-6215) is published monthly, one volume/year, by the American Association for Cancer Research, Inc. (AACR).
Cancer Prevention Research is abstracted and/or indexed in MEDLINE, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.
The journal is printed on paper that meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper).
Back Issues and Single Copy Sales
Subject to availability, single or back issues of Cancer Prevention Research may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact:
AACR Publications Sales & Marketing Department
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Phone: (215) 440-9300; or Toll Free: (855) 744-4667
Cancer Prevention Research Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 440-9337 | E-mail: firstname.lastname@example.org